• Epi Biotech held an investor relations event on Oct. 6, 2026 at Korea Exchange Market Square in Seoul.
• Session ran 15:50–17:30 local time, targeting analysts, institutional investors, venture capital, other KONEX market participants.
• Presentation covered company overview, current operating status, forward plans, followed by a Q&A.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Epi Biotech Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261006600772), on October 06, 2026, and is solely responsible for the information contained therein.